Institutional Ownership Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO). We have compiled data on the 234 institutions that hold shares in the stock, with a total of 61.8 Million shares, which have been reported (via 13F filing form) to have a value of $2.19 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Farallon Capital Management LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
5,767,466
shares
|
$204 Million
0.86% of portfolio
|
Q2 2025
Added 1.18%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
5,682,019
shares
|
$201 Million
0.0% of portfolio
|
Q2 2025
Added 1.38%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,859,002
shares
|
$172 Million
0.0% of portfolio
|
Q2 2024
Added 4.31%
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Aug 14, 2025 Q2 2025 |
3,590,150
shares
|
$127 Million
2.72% of portfolio
|
Q2 2025
Added 2.13%
|
|
Erste Asset Management Gmb H
Vienna, C4 |
Aug 14, 2025 Q2 2025 |
2,326,489
shares
|
$82.3 Million
0.65% of portfolio
|
Q2 2025
Added 4.33%
|
|
Commodore Capital LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,325,000
shares
|
$82.3 Million
7.21% of portfolio
|
Q2 2025
Added 6.41%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,274,249
shares
|
$80.5 Million
0.01% of portfolio
|
Q2 2025
Reduced 1.18%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,951,113
shares
|
$69 Million
0.0% of portfolio
|
Q2 2025
Reduced 20.35%
|
|
Macquarie Group LTD
Australia, C3 |
Aug 14, 2025 Q2 2025 |
1,900,596
shares
|
$67.2 Million
0.08% of portfolio
|
Q2 2025
Added 2.7%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,405,755
shares
|
$49.7 Million
0.0% of portfolio
|
Q2 2025
Added 0.8%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
1,279,754
shares
|
$45.3 Million
2.24% of portfolio
|
Q2 2025
Added 19.62%
|
|
Armistice Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
1,168,000
shares
|
$41.3 Million
0.68% of portfolio
|
Q2 2025
Reduced 42.97%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,142,511
shares
|
$40.4 Million
1.77% of portfolio
|
Q2 2025
New holding
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,120,308
shares
|
$39.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.35%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
1,106,093
shares
|
$39.1 Million
0.01% of portfolio
|
Q2 2025
Reduced 12.36%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,081,470
shares
|
$38.3 Million
0.01% of portfolio
|
Q2 2025
Added 25.24%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,049,360
shares
|
$37.1 Million
0.0% of portfolio
|
Q1 2025
Added 3.35%
|
|
Bnp Paribas Asset Management Holding S.A.
|
Aug 05, 2025 Q2 2025 |
1,016,891
shares
|
$36 Million
0.08% of portfolio
|
Q2 2025
Reduced 0.86%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
989,745
shares
|
$35 Million
2.23% of portfolio
|
Q2 2025
Added 189.25%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
921,586
shares
|
$32.6 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.79%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
882,402
shares
|
$31.2 Million
0.03% of portfolio
|
Q2 2023
Added 26.77%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Aug 13, 2025 Q2 2025 |
877,540
shares
|
$31 Million
0.01% of portfolio
|
Q2 2025
Reduced 8.53%
|
|
Gw&K Investment Management, LLC
Boston, MA |
Aug 11, 2025 Q2 2025 |
868,618
shares
|
$30.7 Million
0.26% of portfolio
|
Q2 2025
Added 6.25%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
791,000
shares
|
$28 Million
0.05% of portfolio
|
Q2 2025
Added 6.46%
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
697,003
shares
|
$24.7 Million
4.73% of portfolio
|
Q2 2025
New holding
|